2834 – Page 81 – China Stock Advice

CPHI [CHINA PHARMAS,] 8-K: ————— FORM 8-K CURRENT REPORTte of Report (Date

[--------------- FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported): December 16, 2013 CHINA PHARMAS, --------------------------------------- Nevada 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer oforporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China) Item 5.07Submission of Matters to a Vote of Security]

By info| 2016-02-07T21:27:28+00:00 December 17th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 2013-12-17, 2834, 8-K, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-3/A: (Original Filing)

[ORM Pre-effective Amendment No. 1 to F REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code,] [Schiff Hardin LLP Letterhead [ December 16, 2013 Board of Directors Skystar Bio-Pharmaceutical Company 4/F Building B, Chuangye Square, No. 48 Keji Road, Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when any applicable] [[Emmel & Klegerman PC Letterhead] December 16, 2013 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Ladies and Gentlemen: Skystar Bio-Pharmaceutical Company December 16, 2013 Page 2 In connection with this opinion letter, we have examined and relied upon copies of the following documents, together with such other documents]

By info| 2016-03-01T03:43:27+00:00 December 16th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 2013-12-16, 2834, PHARMACEUTICAL PREPARATIONS, S-3.A, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-3/A: ORM Pre-effective Amendment No. 1 to F REGISTRATION

[ORM Pre-effective Amendment No. 1 to F REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code,] [Schiff Hardin LLP Letterhead [ December 16, 2013 Board of Directors Skystar Bio-Pharmaceutical Company 4/F Building B, Chuangye Square, No. 48 Keji Road, Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when any applicable] [[Emmel & Klegerman PC Letterhead] December 16, 2013 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Ladies and Gentlemen: Skystar Bio-Pharmaceutical Company December 16, 2013 Page 2 In connection with this opinion letter, we have examined and relied upon copies of the following documents, together with such other documents]

By info| 2016-03-01T03:47:24+00:00 December 16th, 2013|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 2013-12-16, 2834, PHARMACEUTICAL PREPARATIONS, S-3.A, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-3/A: (Original Filing)

[ORM Pre-effective Amendment No. 1 to F REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933ystar Bio-Pharmaceuticalmpany Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer oforporation or organization)de Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xian, Shaanxi Province, P.R. China] [Schiff Hardin Letterhead [ December 16, 2013 Board of Directorsystar Bio-Pharmaceuticalmpany 4/F Building B, Chuangye Square, No. 48 Keji Road, Gaoxin District, Xian, Shaanxi Province, P.R. China Re Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when] [[Emmel & Klegerman PC Letterhead] December 16, 2013ystar Bio-Pharmaceuticalmpany 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xian, Shaanxi Province, P.R. China Ladies and Gentlemen:ystar Bio-Pharmaceuticalmpany December 16, 2013 Page 2 Innnection with this opinion letter, we have examined and relied uponpies of the following documents, together with such other documents we]

By info| 2016-02-05T02:37:54+00:00 December 16th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 2013-12-16, 2834, PHARMACEUTICAL PREPARATIONS, S-3.A, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-3/A: ORM Pre-effective Amendment No. 1 to F REGISTRATION

[ORM Pre-effective Amendment No. 1 to F REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933ystar Bio-Pharmaceuticalmpany Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer oforporation or organization)de Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xian, Shaanxi Province, P.R. China] [Schiff Hardin Letterhead [ December 16, 2013 Board of Directorsystar Bio-Pharmaceuticalmpany 4/F Building B, Chuangye Square, No. 48 Keji Road, Gaoxin District, Xian, Shaanxi Province, P.R. China Re Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when] [[Emmel & Klegerman PC Letterhead] December 16, 2013ystar Bio-Pharmaceuticalmpany 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xian, Shaanxi Province, P.R. China Ladies and Gentlemen:ystar Bio-Pharmaceuticalmpany December 16, 2013 Page 2 Innnection with this opinion letter, we have examined and relied uponpies of the following documents, together with such other documents we]

By info| 2016-02-05T02:38:44+00:00 December 16th, 2013|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 2013-12-16, 2834, PHARMACEUTICAL PREPARATIONS, S-3.A, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-3: (Original Filing)

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code, and telephone number, Bing Mei] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 8 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our report dated April 1, 2013 relating to the consolidated financial statements, which appears in Skystar Bio-Pharmaceutical Company’s Annual Report on Form 10-K for the year ended December 31, 2012. We also consent to] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-3 and related Prospectus of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the December 31, 2011 consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended]

By info| 2016-03-01T03:51:18+00:00 December 4th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 2013-12-04, 2834, PHARMACEUTICAL PREPARATIONS, S-3, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code, and telephone number, Bing Mei] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 8 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our report dated April 1, 2013 relating to the consolidated financial statements, which appears in Skystar Bio-Pharmaceutical Company’s Annual Report on Form 10-K for the year ended December 31, 2012. We also consent to] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-3 and related Prospectus of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the December 31, 2011 consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended]

By info| 2016-03-01T03:52:10+00:00 December 4th, 2013|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 2013-12-04, 2834, PHARMACEUTICAL PREPARATIONS, S-3, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-3: (Original Filing)

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933ystar Bio-Pharmaceuticalmpany Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer oforporation or organization)de Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xian, Shaanxi Province, P.R. China (8629) 8819-3188] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our reportted April 1, 2013 relating to thensolidated financial statements, which appears inystar Bio-Pharmaceuticalmpanys Annual Report on Form 10-K for the year ended December 31, 2012.] [Consent of Independent Registered Public Accounting Firm Wensent to theorporation by reference in this Registration Statement on Form S-3 and related Prospectus ofystar Bio-Pharmaceuticalmpany of our reportted March 30, 2012 relating to the December 31, 2011nsolidated financial statements appearing in the Annual Report on Form 10-K ofystar Bio-Pharmaceuticalmpany for the year ended December 31, 2012,]

By info| 2016-02-05T02:39:43+00:00 December 4th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 2013-12-04, 2834, PHARMACEUTICAL PREPARATIONS, S-3, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933ystar Bio-Pharmaceuticalmpany Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer oforporation or organization)de Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xian, Shaanxi Province, P.R. China (8629) 8819-3188] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our reportted April 1, 2013 relating to thensolidated financial statements, which appears inystar Bio-Pharmaceuticalmpanys Annual Report on Form 10-K for the year ended December 31, 2012.] [Consent of Independent Registered Public Accounting Firm Wensent to theorporation by reference in this Registration Statement on Form S-3 and related Prospectus ofystar Bio-Pharmaceuticalmpany of our reportted March 30, 2012 relating to the December 31, 2011nsolidated financial statements appearing in the Annual Report on Form 10-K ofystar Bio-Pharmaceuticalmpany for the year ended December 31, 2012,]

By info| 2016-02-05T02:40:33+00:00 December 4th, 2013|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 2013-12-04, 2834, PHARMACEUTICAL PREPARATIONS, S-3, SKBI|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): November 22, 2013 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]

By info| 2016-03-03T10:33:17+00:00 November 27th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2013-11-27, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments